The role of cannabis use within a dimensional approach to cannabis use disorders.
- Authors
- Compton, Wilson M; Saha, Tulshi D; Conway, Kevin P; Grant, Bridget F
- Year
- 2009
- Journal
- Drug and alcohol dependence
- PMID
- 19062204
- DOI
- 10.1016/j.drugalcdep.2008.10.009
- PMCID
- PMC3153503
CONTEXT: Cannabis consumption is central to diagnosis of cannabis use disorders; yet, most research on cannabis disorders has focused just on diagnosis or criteria. The present study examines the ability of a frequency and quantity measure of cannabis use as well as cannabis abuse and dependence criteria to discriminate between individuals across the cannabis use disorder continuum. METHOD: A representative sample of USA adults in 2001-2002 (N=43,093) were queried about the past year frequency of cannabis use and each Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) cannabis abuse and dependence criterion. Factor analysis and item response theory (IRT) models were used to define the relationship between observed responses and the underlying unobserved latent trait (cannabis use disorder severity) among past year cannabis users (n=1603). RESULTS: Factor analyses demonstrated a good fit for a one-factor model both with and without the cannabis use criterion and no differential criterion functioning was demonstrated across sex. The IRT model including the cannabis use criterion had discriminatory power comparable to the model without the cannabis use criterion and exceeded the informational value of the model without the cannabis use criterion in mild and moderate ranges of the severity continuum. DISCUSSION: Factor and IRT analyses disprove the validity of the DSM-IV abuse and dependence distinction: A single dimension represented the criteria rather than the two implied by the separate abuse/dependence categories. IRT models identified some dependence criteria to be among the mildest and some abuse criteria to be among the most severe--results inconsistent with the interpretation of DSM-IV cannabis abuse as a milder disorder or prodrome of cannabis dependence. The consumption criterion defined the mild end of the cannabis use disorder continuum and its excellent psychometric properties supported its consideration for inclusion in the next edition of DSM as a criterion for cannabis use disorders. Additional work is needed to identify candidate consumption criteria across all drugs that apply to the milder end of the severity continuum while also improving overall model performance and clinical diagnostic utility.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Are cannabis use problems comparable across individuals using for recreational and medical purposes? An international cross-sectional study of individuals who use self-grown cannabis. | Sznitman SR et al. | β | 2025 | β |
| Cannabis use patterns and association with hyperemesis: A comprehensive review. | Hasler WL et al. | β | 2025 | β |
| Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits. | Galimberti M et al. | β | 2024 | β |
| Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample. | Matson TE et al. | β | 2023 | β |
| Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. | Shmulewitz D et al. | β | 2023 | β |
| High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults. | Di Carlo F et al. | β | 2023 | β |
| Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care. | Matson TE et al. | β | 2023 | β |
| Specific diagnostic criteria identify those at high risk for progression from βpreaddictionβ to severe alcohol use disorder | Miller AP et al. | β | 2023 | β |
| An exploration of multivariate symptom clusters of cannabis use disorder in young adults. | Howe LK et al. | β | 2022 | β |
| Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context. | Mauro PM et al. | β | 2022 | β |
| Impulsivity, Depressive Mood, and Cannabis Use in a Representative Sample of French-Speaking Swiss Young Men. | Rochat L et al. | β | 2022 | β |
| Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users. | Livne O et al. | β | 2021 | β |
| The Etiologic, Theory-Based, Ontogenetic Hierarchical Framework of Alcohol Use Disorder: A Translational Systematic Review of Reviews. | Boness CL et al. | β | 2021 | β |
| Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management. | Gajendran M et al. | β | 2020 | β |
| Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. | Feingold D et al. | β | 2020 | β |
| Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016. | Santaella-Tenorio J et al. | β | 2019 | β |
| Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. | Compton WM et al. | β | 2019 | β |
| Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites. | Richards JE et al. | β | 2019 | β |
| Toward more efficient diagnostic criteria sets and rules: The use of optimization approaches in addiction science. | Stevens JE et al. | β | 2019 | β |
| Patterns and Predictors of Compliance in a Prospective Diary Study of Substance Use and Sexual Behavior in a Sample of Young Men Who Have Sex With Men. | Newcomb ME et al. | β | 2018 | β |
| Substance-related disorders: A review of prevalence and correlates among patients with chronic pain. | Martel MO et al. | β | 2018 | β |
| US Epidemiology of Cannabis Use and Associated Problems. | Hasin DS | β | 2018 | β |
| Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians. | Copeland WE et al. | β | 2017 | β |
| Predictive validity of cannabis consumption measures: Results from a national longitudinal study. | Buu A et al. | β | 2017 | β |
| Cannabis withdrawal and sleep: A systematic review of human studies. | Gates P et al. | β | 2016 | β |
| Is khat use disorder a valid diagnostic entity? | Duresso SW et al. | β | 2016 | β |
| Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys. | Compton WM et al. | β | 2016 | β |
| Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form. | Bonn-Miller MO et al. | β | 2016 | β |
| The Classification of Substance Use Disorders: Historical, Contextual, and Conceptual Considerations. | Robinson SM et al. | β | 2016 | β |
| Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts. | Fairman BJ | β | 2015 | β |
| Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects. | Shmulewitz D et al. | β | 2015 | β |
| Latent class analysis of DSM-5 criteria for opioid use disorders: results from the Iranian National Survey on Mental Health. | Tarrahi MJ et al. | β | 2015 | β |
| Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Goldstein RB et al. | β | 2015 | β |
| The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. | Hasin DS et al. | β | 2015 | β |
| Availability of tobacco products associated with use of marijuana cigars (blunts). | Lipperman-Kreda S et al. | β | 2014 | β |
| Comparing factor, class, and mixture models of cannabis initiation and DSM cannabis use disorder criteria, including craving, in the Brisbane longitudinal twin study. | Kubarych TS et al. | β | 2014 | β |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | β | 2014 | β |
| Response to commentaries. | Martin CS et al. | β | 2014 | β |
| A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5. | Verweij KJ et al. | β | 2013 | β |
| A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents. | Legleye S et al. | β | 2013 | β |
| Contributions of ethnicity to differential item functioning of cannabis abuse and dependence symptoms. | Gizer IR et al. | β | 2013 | β |
| DSM-5 criteria for substance use disorders: recommendations and rationale. | Hasin DS et al. | β | 2013 | β |
| Optimal scaling of the CAST and of SDS Scale in a national sample of adolescents. | Bastiani L et al. | β | 2013 | β |
| Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. | van der Pol P et al. | β | 2013 | β |
| Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users. | van der Pol P et al. | β | 2013 | β |
| The choice of screening instrument matters: the case of problematic cannabis use screening in spanish population of adolescents. | Thanki D et al. | β | 2013 | β |
| The Puzzling Unidimensionality of DSM-5 Substance Use Disorder Diagnoses. | Maccoun RJ | β | 2013 | β |
| Transitions in illicit drug use status over 3 years: a prospective analysis of a general population sample. | Compton WM et al. | β | 2013 | β |
| A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults. | Wu LT et al. | β | 2012 | β |
| Analyses related to the development of DSM-5 criteria for substance use related disorders: 1. Toward amphetamine, cocaine and prescription drug use disorder continua using Item Response Theory. | Saha TD et al. | β | 2012 | β |
| Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. | Hasin DS et al. | β | 2012 | β |
| Dimensions and severity of marijuana consequences: development and validation of the Marijuana Consequences Questionnaire (MACQ). | Simons JS et al. | β | 2012 | β |
| An evaluation of the proposed DSM-5 alcohol use disorder criteria using Australian national data. | Mewton L et al. | β | 2011 | β |
| Assessing the utility of diagnostic criteria: a multisite study on gender identity disorder. | Paap MC et al. | β | 2011 | β |
| Commentary on Shand et al. (2011): Opioid use disorder as a condition of graded severity, similar to other substance use disorders. | Hasin DS | β | 2011 | β |
| Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition. | Kerridge BT et al. | β | 2011 | β |
| Item response theory analysis of binge drinking and its relationship to lifetime alcohol use disorder symptom severity in an American Indian community sample. | Gilder DA et al. | β | 2011 | β |
| Nicotine dependence, abuse and craving: dimensionality in an Israeli sample. | Shmulewitz D et al. | β | 2011 | β |
| Psychometric modeling of cannabis initiation and use and the symptoms of cannabis abuse, dependence and withdrawal in a sample of male and female twins. | Gillespie NA et al. | β | 2011 | β |
| The DSM Guided Cannabis Screen (DSM-G-CS): description, reliability, factor structure and empirical scoring with a clinical sample. | Alexander D et al. | β | 2011 | β |
| The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. | van der Pol P et al. | β | 2011 | β |
| The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators. | Piontek D et al. | β | 2011 | β |
| Cannabis dimensionality: dependence, abuse and consumption. | Beseler CL et al. | β | 2010 | β |
| Continuous, categorical and mixture models of DSM-IV alcohol and cannabis use disorders in the Australian community. | Baillie AJ et al. | β | 2010 | β |
| Dimensionality of DSM-IV nicotine dependence in a national sample: an item response theory application. | Saha TD et al. | β | 2010 | β |
| Expectancies and marijuana use frequency and severity among young females. | Hayaki J et al. | β | 2010 | β |
| Exploring the role of a nicotine quantity-frequency use criterion in the classification of nicotine dependence and the stability of a nicotine dependence continuum over time. | McBride O et al. | β | 2010 | β |
| Item response theory analysis of DSM-IV criteria for inhalant-use disorders in adolescents. | Perron BE et al. | β | 2010 | β |
| Marijuana use subtypes in a community sample of young adult women. | de Dios MA et al. | β | 2010 | β |
| Measuring addiction propensity and severity: the need for a new instrument. | Conway KP et al. | β | 2010 | β |
| The family history method in disordered gambling research: a comparison of reports obtained from discordant twin pairs. | Slutske WS et al. | β | 2010 | β |
| "Youthful epidemic" or diagnostic bias? Differential item functioning of DSM-IV cannabis use criteria in an Australian general population survey. | Mewton L et al. | β | 2010 | β |
| Item response theory analysis of lifetime cannabis-use disorder symptom severity in an American Indian community sample. | Gilder DA et al. | β | 2009 | β |